American Heart Association
New Onset HFpEF and “LVH”—Don't Miss the Treatable Zebra: How to Diagnose and Treat Cardiac Amyloidosis in 2025
Cardiovascular Seminar
275-277
Nov 8th , 03:15 PM - 04:30 PM
Alexander Kevin, Nativi-nicolau Jose, Raymer David
Final Pr. ID: -
Authors: Alexander Kevin, Nativi-nicolau Jose, Raymer David
03 : 25 PM
I’m am Worried My Patient May have Cardiac Amyloidosis. A Practical Algorithm to Make the Diagnosis.
Hanna Mazen, Sailer Christine, Kittleson Michelle
Final Pr. ID: -
Authors: Hanna Mazen, Sailer Christine, Kittleson Michelle
Maurer Mathew, Witteles Ronald
Final Pr. ID: -
Authors: Maurer Mathew, Witteles Ronald
Sarswat Nitasha, Dasgupta Noel
Final Pr. ID: -
Authors: Sarswat Nitasha, Dasgupta Noel
Ambardekar Amrut, Panjrath Gurusher
Final Pr. ID: -
Authors: Ambardekar Amrut, Panjrath Gurusher
04 : 05 PM
Do Emerging HFpEF Treatments Work? The Role of Non-disease Modifying Treatments including SGLT2i, MRAs, GLP1s, and implantable hemodynamic monitors in Cardiac Amyloidosis.
Cuddy Sarah, Griffin Jan
Final Pr. ID: -
Authors: Cuddy Sarah, Griffin Jan
Maurer Mathew, Witteles Ronald
Final Pr. ID: -
Authors: Maurer Mathew, Witteles Ronald
04 : 05 PM
Do Emerging HFpEF Treatments Work? The Role of Non-disease Modifying Treatments including SGLT2i, MRAs, GLP1s, and implantable hemodynamic monitors in Cardiac Amyloidosis.
Cuddy Sarah, Griffin Jan
Final Pr. ID: -
Authors: Cuddy Sarah, Griffin Jan
03 : 25 PM
I’m am Worried My Patient May have Cardiac Amyloidosis. A Practical Algorithm to Make the Diagnosis.
Hanna Mazen, Sailer Christine, Kittleson Michelle
Final Pr. ID: -
Authors: Hanna Mazen, Sailer Christine, Kittleson Michelle
Alexander Kevin, Nativi-nicolau Jose, Raymer David
Final Pr. ID: -
Authors: Alexander Kevin, Nativi-nicolau Jose, Raymer David
Ambardekar Amrut, Panjrath Gurusher
Final Pr. ID: -
Authors: Ambardekar Amrut, Panjrath Gurusher
Sarswat Nitasha, Dasgupta Noel
Final Pr. ID: -
Authors: Sarswat Nitasha, Dasgupta Noel